In summary, we have uncovered a novel molecular mechanism involving CRNDE that underlies HCC proliferation and sorafenib resistance through chromatin relaxation and induction of epigenetic regulatory complex binding to the EGFR promoter to enhance its transcriptional activity. The gene discussed is EGFR; the disease is hepatocellular carcinoma.